Ascendis Pharma A/S
ASND201.600USD
-2.110-1.04%
Fechamento 10/31, 16:00（ET）Cotações atrasadas em 15 min
12.33BValor de mercado
PerdaP/L TTM
Mais detalhes de Ascendis Pharma A/S Empresa
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
Informações de Ascendis Pharma A/S
Código da empresaASND
Nome da EmpresaAscendis Pharma A/S
Data de listagemJan 28, 2015
CEOMr. Jan Moller Mikkelsen
Número de funcionários- -
Tipo de títulosDepository Receipt
Fim do ano fiscalJan 28
EndereçoTuborg Boulevard 12
CidadeHELLERUP
Bolsa de valoresNASDAQ Global Select Consolidated
PaísDenmark
Código postal2900
Telefone4570222244
Sitehttps://ascendispharma.dk/
Código da empresaASND
Data de listagemJan 28, 2015
CEOMr. Jan Moller Mikkelsen
Executivos da empresa Ascendis Pharma A/S
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+198.45%
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
1.86K
+100.43%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
1.59K
+78.59%
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
1.09K
+178.01%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.09K
+178.01%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
364.00
--
Mr. Mads Bodenhoff
Mr. Mads Bodenhoff
Senior Vice President, Head of Finance and Principal Accounting Officer
Senior Vice President, Head of Finance and Principal Accounting Officer
193.00
--
Mr. Donovan (Jay) Wu
Mr. Donovan (Jay) Wu
Executive Vice President, U.S. President
Executive Vice President, U.S. President
--
--
Dr. Aimee Shu,, M.D.
Dr. Aimee Shu,, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
--
Mr. William Carl (Bill) Fairey, Jr.
Mr. William Carl (Bill) Fairey, Jr.
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+198.45%
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
1.86K
+100.43%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
1.59K
+78.59%
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
1.09K
+178.01%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.09K
+178.01%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
364.00
--
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Commercial sale of products
153.66M
97.23%
Rendering of services
3.57M
2.26%
License
812.00K
0.51%
Por RegiãoUSD
Nome
Receita
Proporção
North America
108.45M
68.62%
Europe
27.89M
17.65%
Rest of world
21.70M
13.73%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Commercial sale of products
153.66M
97.23%
Rendering of services
3.57M
2.26%
License
812.00K
0.51%
Distribuição de ações
Atualizado em: dom, 12 de out
Atualizado em: dom, 12 de out
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
RA Capital Management, LP
16.88%
Westfield Capital Management Company, L.P.
8.95%
Avoro Capital Advisors LLC
8.18%
Janus Henderson Investors
7.27%
Fidelity Management & Research Company LLC
6.86%
Outro
51.87%
Investidores
Investidores
Proporção
RA Capital Management, LP
16.88%
Westfield Capital Management Company, L.P.
8.95%
Avoro Capital Advisors LLC
8.18%
Janus Henderson Investors
7.27%
Fidelity Management & Research Company LLC
6.86%
Outro
51.87%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
41.98%
Investment Advisor
36.23%
Venture Capital
17.21%
Hedge Fund
6.13%
Private Equity
1.86%
Research Firm
1.70%
Individual Investor
0.77%
Pension Fund
0.32%
Participação acionária institucional
Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
509
64.52M
105.91%
-6.64M
2025Q2
502
70.53M
116.83%
-1.34M
2025Q1
513
68.89M
114.10%
-3.55M
2024Q4
488
67.37M
111.00%
-7.76M
2024Q3
475
65.25M
107.66%
-6.23M
2024Q2
459
63.44M
108.94%
-9.21M
2024Q1
453
63.54M
109.13%
-8.68M
2023Q4
430
62.90M
109.00%
-9.55M
2023Q3
414
62.85M
109.61%
-11.90M
2023Q2
426
63.03M
109.93%
-13.27M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
RA Capital Management, LP
10.28M
16.88%
--
--
Jun 30, 2025
Westfield Capital Management Company, L.P.
5.45M
8.95%
-27.86K
-0.51%
Jun 30, 2025
Avoro Capital Advisors LLC
4.98M
8.18%
-238.00K
-4.56%
Jun 30, 2025
Janus Henderson Investors
4.43M
7.27%
-59.16K
-1.32%
Jun 30, 2025
Fidelity Management & Research Company LLC
4.18M
6.86%
-125.41K
-2.91%
Jun 30, 2025
Artisan Partners Limited Partnership
3.99M
6.55%
-266.20K
-6.25%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
3.58M
5.88%
+529.72K
+17.35%
Jun 30, 2025
Capital International Investors
3.05M
5%
+172.14K
+5.99%
Jun 30, 2025
MFS Investment Management
1.90M
3.11%
+23.62K
+1.26%
Jun 30, 2025
T. Rowe Price Associates, Inc.
1.88M
3.08%
-380.61K
-16.87%
Jun 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: seg, 6 de out
Atualizado em: seg, 6 de out
Nome
Proporção
Harbor Health Care ETF
16.34%
AdvisorShares Dorsey Wright ADR ETF
2.66%
American Century Focused Dynamic Growth ETF
2.5%
Virtus LifeSci Biotech Products ETF
1.89%
Tema Heart & Health ETF
1.51%
ProShares Ultra Nasdaq Biotechnology
1.2%
Invesco Nasdaq Biotechnology ETF
1.2%
Main Thematic Innovation ETF
1.07%
Putnam Sustainable Future ETF
1.03%
JPMorgan Healthcare Leaders ETF
0.76%
Ver Mais
Harbor Health Care ETF
Proporção16.34%
AdvisorShares Dorsey Wright ADR ETF
Proporção2.66%
American Century Focused Dynamic Growth ETF
Proporção2.5%
Virtus LifeSci Biotech Products ETF
Proporção1.89%
Tema Heart & Health ETF
Proporção1.51%
ProShares Ultra Nasdaq Biotechnology
Proporção1.2%
Invesco Nasdaq Biotechnology ETF
Proporção1.2%
Main Thematic Innovation ETF
Proporção1.07%
Putnam Sustainable Future ETF
Proporção1.03%
JPMorgan Healthcare Leaders ETF
Proporção0.76%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
